Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Total Current Liabilities: 2020-2024

Historic Total Current Liabilities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $52.2 million.

  • Oncology Institute's Total Current Liabilities rose 4025.71% to $65.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.6 million, marking a year-over-year increase of 4025.71%. This contributed to the annual value of $52.2 million for FY2024, which is 5009.49% up from last year.
  • Latest data reveals that Oncology Institute reported Total Current Liabilities of $52.2 million as of FY2024, which was up 5009.49% from $34.8 million recorded in FY2023.
  • Oncology Institute's 5-year Total Current Liabilities high stood at $52.2 million for FY2024, and its period low was $28.6 million during FY2020.
  • Over the past 5 years, Oncology Institute's median Total Current Liabilities value was $29.8 million (recorded in 2021), while the average stood at $35.0 million.
  • Per our database at Business Quant, Oncology Institute's Total Current Liabilities dropped by 26.18% in 2022 and then skyrocketed by 5009.49% in 2024.
  • Annual analysis of 5 years shows Oncology Institute's Total Current Liabilities stood at $28.6 million in 2020, then grew by 4.16% to $29.8 million in 2021, then fell by 0.26% to $29.7 million in 2022, then increased by 17.05% to $34.8 million in 2023, then surged by 50.09% to $52.2 million in 2024.
  • Its Total Current Liabilities was $52.2 million in FY2024, compared to $34.8 million in FY2023 and $29.7 million in FY2022.